Published in Drug Week, June 16th, 2006
AC-100 is a synthetic peptide derived from an endogenous human protein produced primarily by bone and dental cells and has previously been shown to specifically promote new dentin formation in teeth and bone formation at fracture and healing sites with no ectopic calcification. The data were presented by Catherine Middleton-Hardie of Acologix who was given a Young Investigator's Award for the submitted abstract.
Want to see the full article?
Welcome to NewsRx!
Learn more about a six-week, no-risk free trial of Drug Week
NewsRx also is available at LexisNexis, Gale, ProQuest, Factiva, Dialog, Thomson Reuters, NewsEdge, and Dow Jones.